11 employees
Neurinnov provides the design, development, and commercialization of active implantable medical devices and services.
2018
$3.4M
from 2 investors over 2 rounds
NEURINNOV raised $3.4M on December 12, 2021
Investors: SOFILARO Capital Investissement and UI Investissement